Stucco & Cement Patch (Asbestos-Containing Formula) — Artra-Synkoloid

Artra-Synkoloid’s Stucco & Cement Patch was a finishing and repair compound marketed for surface preparation, patching, and decorative texturing applications. Litigation records document that certain formulations of this product contained asbestos as a functional ingredient, placing it among the category of asbestos-containing joint compounds and patching materials that became subjects of personal injury litigation during the latter decades of the twentieth century.

Product Description

Artra-Synkoloid produced a line of surface finishing products under its Synkoloid brand, including stucco and cement patch compounds intended for both interior and exterior repair work. These materials were designed to fill cracks, resurface damaged areas, and create finished textures on walls and ceilings. The compound was formulated to adhere to masonry, plaster, gypsum board, and similar substrates, making it a versatile product for construction, renovation, and maintenance projects.

The product was sold in dry powder or pre-mixed forms and was applied by trowel, knife, or hand. It was marketed to professional tradespeople and general contractors, as well as to industrial facilities performing routine maintenance on their structures. Synkoloid-brand products were distributed through building supply channels and were used across a range of commercial, industrial, and institutional settings.

Litigation records document that the Stucco & Cement Patch formula, during at least a portion of its production history, incorporated asbestos mineral fibers. The precise years of manufacture for asbestos-containing formulations have been established through product testing records, corporate documentation, and testimony introduced in civil litigation.

Asbestos Content

Plaintiffs alleged that Artra-Synkoloid’s Stucco & Cement Patch contained asbestos in quantities sufficient to release respirable fibers during normal use and handling. Asbestos was commonly added to cement patch, stucco, and joint compound products during this era for several functional reasons: the fibers improved tensile strength, reduced cracking during drying, provided thermal resistance, and improved workability when mixed with water.

Chrysotile (white asbestos) was the form most commonly incorporated into patching and finishing compounds of this type, though litigation records in related product categories have also identified the presence of amphibole asbestos varieties in some cement-based materials. The specific fiber type and concentration present in Artra-Synkoloid’s formula have been addressed through product sampling, laboratory analysis, and corporate records introduced as evidence in personal injury proceedings.

Plaintiffs alleged that the asbestos content of the product was not disclosed on product labeling during the period of use, and that workers and end users were not provided adequate warning of the health hazards associated with fiber inhalation.

How Workers Were Exposed

Industrial workers and construction tradespeople who handled or worked in proximity to Artra-Synkoloid Stucco & Cement Patch represented the primary population at risk for asbestos fiber exposure. Litigation records document several mechanisms through which exposure occurred during the ordinary use of this and similar patching compound products.

Mixing and preparation presented a significant exposure opportunity. When the dry powder formulation was combined with water, agitation of the dry material released clouds of fine particulate matter containing asbestos fibers. Workers performing this task in enclosed or poorly ventilated spaces faced repeated and concentrated inhalation exposure.

Application and surface work generated additional fiber release. Troweling, spreading, and feathering the compound across surfaces could disturb the material and release fibers into the breathing zone of the worker performing the application.

Sanding and abrading dried compound was among the most hazardous activities associated with products of this type. Once the patching compound dried and cured, sanding to achieve a smooth finish broke apart the hardened material and generated fine airborne dust. Litigation records in the broader joint compound and patching product category consistently identify sanding as a high-exposure task, as it produces respirable-sized particles that remain suspended in air for extended periods.

Disturbance during demolition and renovation created secondary exposure for workers who encountered previously applied Artra-Synkoloid compound in older structures. Cutting, chipping, and removing patched or stuccoed surfaces without protective measures could release fibers from the cured material.

Industrial workers generally—including maintenance personnel at manufacturing plants, warehouses, institutional facilities, and commercial buildings—were among those who used products of this type for routine repair and upkeep tasks. These workers often performed patching work as part of broader maintenance duties rather than as dedicated tradespeople, and they were frequently without respiratory protection or awareness of the asbestos hazard in the materials they handled.

Plaintiffs alleged that repeated exposure to asbestos-containing dust from this and similar products over the course of occupational careers contributed to the development of asbestos-related diseases, including mesothelioma, asbestosis, and lung cancer. Asbestos-related diseases typically have latency periods of twenty to fifty years between initial exposure and clinical diagnosis, meaning workers exposed to products from this era may be receiving diagnoses today.

Artra-Synkoloid’s Stucco & Cement Patch falls within the category of litigated asbestos-containing products for which no dedicated bankruptcy trust fund has been identified in available trust fund documentation. Individuals diagnosed with asbestos-related diseases following exposure to this product may pursue legal remedies through civil litigation in state or federal court.

Civil litigation remains the principal avenue for individuals harmed by exposure to this product. Plaintiffs alleged in filed cases that Artra-Synkoloid and related corporate entities were liable for failure to warn, negligence, and defective product design in connection with asbestos-containing formulations of the Stucco & Cement Patch compound. Litigation records document that personal injury and wrongful death claims arising from exposure to this and related Synkoloid-brand products have been filed in asbestos dockets across multiple jurisdictions.

Multi-defendant claims are common in asbestos litigation, as most individuals with occupational exposure encountered numerous asbestos-containing products over the course of their careers. An asbestos exposure assessment conducted by a qualified attorney can identify all potentially liable manufacturers, contractors, and employers, and may also identify applicable asbestos bankruptcy trust funds from other responsible parties whose claims are administered separately.

Eligibility considerations for any civil claim typically require documentation of a qualifying diagnosis (mesothelioma, asbestosis, lung cancer with asbestos exposure history, or other asbestos-related disease), evidence establishing exposure to the specific product, and a claim filed within the applicable statute of limitations for the relevant jurisdiction.

Individuals who worked with Artra-Synkoloid Stucco & Cement Patch, or family members of deceased workers with documented exposure, should consult with an attorney experienced in asbestos personal injury litigation to evaluate the facts of their specific case and identify all available legal options.